Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Obes Surg ; 31(4): 1401-1410, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33387264

ABSTRACT

BACKGROUND: Bariatric medical tourism (BMT) is a rapidly expanding industry, with over 650 million people with obesity worldwide and total number rising by over 300% between 2003 and 2014. The overall health tourism industry is worth over $400 billion/year. METHODS: International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) conducted a global survey to analyze the details of BMT and the perceptions of bariatric health care professionals (HCP) regarding BMT. RESULTS: A total of 383 bariatric HCP's with experience of 272,548 procedures responded from 65 countries. Seventy-three percent of respondents had managed BMT patients, whilst low cost of surgery was felt to be the driving factor in 77% of cases. The USA contributed the most patients travelling for BMT with 11.6%. Twenty-four percent of respondents stated that they had no access to adequate notes regarding the patient's operation, whilst 12% felt BMT is associated with a higher mortality. Only 49% of respondents felt that IFSO guidelines were followed by the operating surgeon. Sleeve gastrectomy was the commonly offered surgery and an overall mean operation cost was $8716. Nearly 64% of respondents felt BMT needed better coordination between practitioners, whilst almost 85% of respondents supported the idea of a forum to facilitate safe BMT worldwide. CONCLUSION: This IFSO survey has outlined the current BMT trends worldwide and highlighted areas of concern in the care of such patients. It has expanded our knowledge and should be used as a starting point to establish international forums to aid collaboration.


Subject(s)
Bariatric Surgery , Bariatrics , Metabolic Diseases , Obesity, Morbid , Health Personnel , Humans , Obesity/surgery , Obesity, Morbid/surgery , Perception , Surveys and Questionnaires , Tourism
2.
J Laparoendosc Adv Surg Tech A ; 30(2): 206-209, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31794681

ABSTRACT

Aim of the Study: Esophageal dilatations are commonly performed in pediatric patients who have undergone an esophageal atresia/tracheoesophageal fistula (EA/TEF) repair or following caustic injury. We sought to compare the practice of esophageal dilatation across different specialties. Methods: We analyzed all patients who had an esophageal dilatation at our center between April 2014 and December 2018. Patients were identified via prospectively maintained databases and clinical coding records. Patients had a combination of dilatations under each specialty: interventional radiology (IR), surgery, and gastroenterology. Results: Thirty-five individual patients underwent 226 dilatations, median dilatations per patient was 3 (1-40). The median age at first dilatation was 18 months (1-194 months). Sixty-eight percent of patients had a previous EA/TEF repair. IR performed 59% of dilatations, surgeons 26%, and 15% by gastroenterologists. Surgeons more frequently were performing initial dilatations (P < .05) and performed more dilatations in EA/TEF patients (P < .0001). There was a significant difference between the time from a surgical dilatation until the next dilatation, 3.7 months, compared with an IR dilatation, 1.8 months (ANOVA, P < .05). Surgeons more frequently increased the size of balloon used (57% versus 33% versus 39%, P < .01). There was no significant difference in balloon size between specialties or in the incremental increase in size between subsequent dilatations. There was one postprocedure perforation, managed conservatively (complication rate = 0.4%). Conclusion: We have demonstrated that on average, patients wait longer after a surgical dilatation until their next procedure, and surgical teams are more likely to increase the size of the dilating balloon. Surgeons tend to be more involved in their postoperative patients in the initial phases of stricture management. Our results suggest the feasibility and safety of a multispecialty approach for these patients.


Subject(s)
Dilatation/statistics & numerical data , Esophageal Stenosis/therapy , Gastroenterology/statistics & numerical data , General Surgery/statistics & numerical data , Radiology, Interventional/statistics & numerical data , Adolescent , Burns, Chemical/complications , Child , Child, Preschool , Dilatation/adverse effects , Dilatation/methods , Esophageal Atresia/surgery , Esophageal Stenosis/etiology , Humans , Infant , Infant, Newborn , Postoperative Complications/etiology , Postoperative Complications/therapy , Tracheoesophageal Fistula/surgery , Treatment Outcome
3.
J Hand Surg Asian Pac Vol ; 24(2): 189-194, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31035876

ABSTRACT

Background: Hand and upper limb soft tissue infections result in significant disability and loss of productivity. Many infections have been shown to follow a seasonal variation, however little is known about this is the context of upper limb soft tissue infections. We aimed to evaluate seasonal variation in acute bacterial, hand and upper limb skin and soft-tissue infections, and correlate findings with key environmental variables. Methods: Hand and upper limb soft tissue infection cases from 2006-2016 were retrieved from a single UK center. Cases were reviewed for microbiology culture and sensitivity. Correlation between cases and season, temperature and humidity was assessed. Results: 206 cases were identified for inclusion. Specimens were sent for microbiology in 76.4% of cases. Of these 78.9% were culture positive, 47.6% exhibited antibiotic resistance and 16.9% were multi-resistant. There was a significant difference between season and culture positive cases, with significantly more culture positive cases in the summer vs. winter on post-hoc analysis (p = 0.004). There was a significant positive correlation between higher temperatures and number of culture positive cases (r = 0.75). There was no significant correlation between temperature and antibiotic resistance (r = 0.5) or between humidity and culture positive cases (r = -0.42). Conclusions: This study demonstrates a seasonal variation in hand and upper limb infections, with a significant correlation between infection rates and ambient temperature. Appreciating seasonal variability of these infections could prove beneficial for surgical planning, public health recommendations and antibiotic guidelines. However, further international data is needed to understand potential mechanisms involved.


Subject(s)
Hand/microbiology , Seasons , Soft Tissue Infections/epidemiology , Upper Extremity/microbiology , Humans , Humidity , Retrospective Studies , Soft Tissue Infections/microbiology , Temperature , United Kingdom/epidemiology
4.
ANZ J Surg ; 88(11): E782-E786, 2018 11.
Article in English | MEDLINE | ID: mdl-30014560

ABSTRACT

BACKGROUND: Colorectal cancer is one of the most common malignancies worldwide; whilst approximately 20% of patients have hepatic disease at presentation. Hepatic resection remains the gold standard of care; however, it is associated with significant morbidity. We sought to establish whether the lymphocyte-to-monocyte ratio (LMR) could help predict post-operative complications, thus improving patient outcomes. METHODS: We performed a retrospective cohort study of patients undergoing hepatic resection at a single centre. Baseline demographics and complications within 30 days following surgery were recorded. White blood cell counts and C-reactive protein (CRP) were recorded pre-operatively, and until post-operative day 7. RESULTS: A total of 188 operations were included. About 47.3% of resections had a complicated recovery, of which 31.46% were major. The median LMR was 1.29 across the cohort, 1.60 for uncomplicated procedures, 1.14 for those with complications and 0.85 in major complications. For detecting major complications versus an uncomplicated recovery, median LMR was the best parameter (area under the curve 0.78), whilst it was the only parameter to accurately predict such complications within 48 hours of surgery (area under the curve 0.72 on day 1). It was consistently the most accurate parameter at detecting uncomplicated versus complicated recovery, minor versus major complications, and major complications versus an uncomplicated recovery, at numerous timepoints over the post-operative period. CONCLUSION: The LMR appears better at predicting complications following hepatic resection for colorectal liver metastases, as opposed to conventionally measured parameters.


Subject(s)
Adenocarcinoma/secondary , Colorectal Neoplasms/pathology , Decision Support Techniques , Hepatectomy , Leukocytes/metabolism , Liver Neoplasms/secondary , Postoperative Complications/etiology , Adenocarcinoma/surgery , Biomarkers/blood , Female , Follow-Up Studies , Humans , Leukocyte Count , Liver Neoplasms/surgery , Lymphocytes/metabolism , Male , Monocytes/metabolism , Postoperative Complications/blood , Postoperative Complications/diagnosis , ROC Curve , Retrospective Studies , Risk Assessment , Risk Factors
5.
J Surg Oncol ; 117(5): 1058-1065, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29448304

ABSTRACT

BACKGROUND AND OBJECTIVES: Approximately 30-50% of patients with colorectal cancer develop liver metastasis for which liver resection is the only hope for potential cure. However, hepatic resection is associated with considerable morbidity. The aim was to detect early complications by utilising the neutrophil: lymphocyte ratio (NLR). METHODS: We performed a retrospective cohort study of patients undergoing hepatic resection at a single institution between 2008 and 2016. Baseline demographics and complications within 30 days following surgery were recorded, with blood tests measured until day 7. Statistical analysis was performed using Mann Whitney and ROC analysis. RESULTS: One hundred eighty-eight operations were included. 47.3% had an associated complication, of which 31.46% were major. The median NLR was 6.31 across the cohort, 5.44 for uncomplicated procedures, 7.0 for complications and 10.65 in major complications. Median NLR was the best parameter for detecting major complications versus minor complications (AUC 0.74) as opposed to lymphocytes (AUC 0.65), neutrophils (AUC 0.60), and CRP (AUC 0.60). The diagnostic ability of NLR increased further when predicting major complications versus an uncomplicated recovery (AUC 0.78), and it was the only significant parameter in the early post-operative period on days 2, 3, and 4 (AUC 0.70, 0.72, and 0.75). CONCLUSIONS: The NLR may have a role in predicting complications following hepatic resection for CLM, and with earlier detection, potentially improving outcomes.


Subject(s)
Colorectal Neoplasms/pathology , Hepatectomy/adverse effects , Liver Neoplasms/secondary , Lymphocytes/pathology , Neutrophils/pathology , Postoperative Complications/diagnosis , Aged , Colorectal Neoplasms/surgery , Female , Follow-Up Studies , Humans , Liver Neoplasms/surgery , Lymphatic Metastasis , Male , Middle Aged , Neoplasm Invasiveness , Prognosis , Prospective Studies , Survival Rate
6.
ANZ J Surg ; 88(9): 891-895, 2018 09.
Article in English | MEDLINE | ID: mdl-29316119

ABSTRACT

BACKGROUND: We report on our experience of the surgical management and outcomes of 11 patients with solid pseudopapillary tumour of the pancreas (SPT). We sought to correlate the immunohistochemical staining of these tumours with that previously reported in the literature. METHODS: A retrospective analysis of the clinical presentation, radiological findings, surgical treatment, histopathological characteristics and outcomes for patients surgically managed with SPT at The Royal London Hospital. A literature search was performed to analyse the immunohistochemical stains commonly used to diagnose SPT. RESULTS: Between August 2006 and April 2016, 10 females and one male patient underwent surgery for SPT. The localization of the tumour was in the pancreatic head in two patients, one in the neck, three in the body and five in the tail. All 11 patients had localised disease. Six patients suffered post-surgical complications. Histopathology shows immunoreactivity for: ß-catenin, vimentin, CD-10, CD-56, α1-antitrypsin and negative staining for synaptophysin and chromogranin. At a median of 24 months of follow-up, the disease-free survival rate was 100% and no recurrence was noted. A literature review generated 38 suitable articles with 116 individual cases of SPT, with high expression of vimentin and neuron specific enolase throughout, and low rates of chromogranin and synatophysin positivity. CONCLUSION: SPT is rare and affects mostly young women. An accurate diagnosis is important as the relative indolent behaviour can be managed with surgical resection even when large in size, bringing excellent long-term outcomes.


Subject(s)
Carcinoma, Papillary/pathology , Pancreas/pathology , Pancreatic Neoplasms/pathology , Adolescent , Adult , Carcinoma, Papillary/metabolism , Carcinoma, Papillary/surgery , Chromogranins/metabolism , Disease-Free Survival , Female , Humans , Immunohistochemistry/methods , Male , Middle Aged , Pancreas/metabolism , Pancreas/surgery , Pancreatic Neoplasms/metabolism , Pancreatic Neoplasms/surgery , Phosphopyruvate Hydratase/metabolism , Postoperative Complications/epidemiology , Retrospective Studies , Treatment Outcome , Vimentin/metabolism , Young Adult
7.
BMJ Case Rep ; 20172017 Aug 16.
Article in English | MEDLINE | ID: mdl-28814593

ABSTRACT

The number of permanent colostomies carried out in the United Kingdom is approximately 6400 per year1. Stomal prolapse is a known complication of colostomy formation. We presented the first case of small bowel herniation into a healthy stomal prolapse with subsequent ischaemia of the herniated bowel in a 102-year-old patient. This rare sequela of a relatively common stomal complication highlights an important consideration when faced with a large prolapse presenting acutely. It also raises an important discussion point for the management of our ever-ageing patient population.


Subject(s)
Cecal Diseases/diagnosis , Infarction/diagnosis , Adenocarcinoma/surgery , Aged, 80 and over , Cecal Diseases/complications , Cecal Diseases/surgery , Colonic Neoplasms/surgery , Colostomy , Diagnosis, Differential , Humans , Infarction/complications , Infarction/surgery , Male , Prolapse , Reoperation
8.
Case Rep Gastroenterol ; 10(3): 545-552, 2016.
Article in English | MEDLINE | ID: mdl-27920640

ABSTRACT

Ampullary adenomas are a rare clinical entity, occurring at a rate of 0.04-0.12% in the general population. They are premalignant lesions which have the capability to progress to malignancy, and they should be excised if they are causing immediate symptoms and/or are likely to degenerate to carcinoma. Intestinal intussusception in adults is rare and, unlike in children, is often due to a structural pathology. Intussuscepting duodenal/ampullary adenomas have been reported in the literature on 13 previous occasions, however never before with this presentation. We report the case of a woman who presented with a 1-year history of recurrent chest infections. She was treated with numerous antibiotics, whilst intermittent symptoms of recurrent vomiting and weight loss were initially attributed to her lung infections. A chest CT demonstrated multiple cavitating lung lesions, whilst an obstructing polypoid mass was noted at D2 on dedicated abdominal imaging. Due to ongoing nutritional problems, she had a semi-urgent pancreaticoduodenectomy. Intraoperative findings demonstrated a large mass at D2 with a duodeno-duodenal intussusception. Histological analysis reported a duodenal, ampullary, low-grade tubular adenoma, 75 × 28 × 30 mm in size, with intussusception and complete resection margins. The patient recovered well and was discharged on postoperative day 10, with no complications to date. Ampullary adenomas may present with obstruction of the main gastrointestinal tract and/or biliary/pancreatic ducts. Common presentations include gastric outlet obstruction, gastrointestinal bleeding or acute pancreatitis. This unique presentation should remind clinicians of the need to investigate recurrent chest infections for a possible gastrointestinal cause.

9.
World J Surg ; 40(6): 1397-403, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26813540

ABSTRACT

BACKGROUND: Complications following esophagectomy are a significant source of morbidity. The aim of this study was to investigate the utility of the neutrophil:lymphocyte ratio (NLR) in the early identification of complications following esophagectomy, as compared to other routinely available parameters. METHODS: We performed a retrospective cohort study of patients undergoing Ivor-Lewis esophagectomy at a single centre. Baseline characteristics and complications occurring within the first 30 days of surgery were recorded. White blood cell counts and C-reactive protein (CRP) levels immediately following surgery (day 0) and over the subsequent three postoperative days were analysed. RESULTS: Sixty-five patients were included, of whom 29 (45 %) developed complications. The median NLR was similar among patients with and without a complicated recovery on day 0 (12.7 vs 13.6, p = 0.70) and day 1 (10.0 vs 9.3, p = 0.29). Patients who subsequently developed complications had a higher NLR on day 2 (11.8 vs 7.5, p < 0.001) and day 3 (9.0 vs 6.5, p = 0.001) compared to those whose recovery was uncomplicated. Receiver-operating-characteristic plots for the diagnostic performance of the NLR, neutrophil count, lymphocyte count and CRP level at each time point demonstrated that the NLR on day 2 had the greatest discriminatory ability in predicting complications, with an area under the curve of 0.83 (95 % CI 0.73-0.94). An NLR of >8.3 on day 2 had a sensitivity of 93 % and a specificity of 72 % for predicting complications. CONCLUSION: The NLR is a simple and routinely available parameter which has a high sensitivity in the early detection of complications following esophagectomy.


Subject(s)
Esophageal Neoplasms/surgery , Esophagectomy/adverse effects , Lymphocytes , Neutrophils , Postoperative Care/methods , Aged , Biomarkers/blood , C-Reactive Protein/metabolism , Early Diagnosis , Esophageal Neoplasms/blood , Female , Humans , Leukocyte Count , Lymphocyte Count , Male , Middle Aged , Postoperative Complications/blood , Postoperative Complications/diagnosis , Postoperative Period , ROC Curve , Retrospective Studies , Sensitivity and Specificity
10.
PLoS One ; 10(6): e0131344, 2015.
Article in English | MEDLINE | ID: mdl-26121130

ABSTRACT

PURPOSE: The sirtuin gene family has been linked with tumourigenesis, in both a tumour promoter and suppressor capacity. Information regarding the function of sirtuins in pancreatic cancer is sparse and equivocal. We undertook a novel study investigating SIRT1-7 protein expression in a cohort of pancreatic tumours. The aim of this study was to establish a protein expression profile for SIRT1-7 in pancreatic ductal adenocarcinomas (PDAC) and to determine if there were associations between SIRT1-7 expression, clinico-pathological parameters and patient outcome. MATERIAL AND METHODS: Immunohistochemical analysis of SIRT1-7 protein levels was undertaken in a tissue micro-array comprising 77 resected PDACs. Statistical analyses determined if SIRT1-7 protein expression was associated with clinical parameters or outcome. RESULTS: Two sirtuin family members demonstrated significant associations with clinico-pathological parameters and patient outcome. Low level SIRT3 expression in the tumour cytoplasm correlated with more aggressive tumours, and a shorter time to relapse and death, in the absence of chemotherapeutic intervention. Low levels of nuclear SIRT7 expression were also associated with an aggressive tumour phenotype and poorer outcome, as measured by disease-free and disease-specific survival time, 12 months post-diagnosis. CONCLUSIONS: Our data suggests that SIRT3 and SIRT7 possess tumour suppressor properties in the context of pancreatic cancer. SIRT3 may also represent a novel predictive biomarker to determine which patients may or may not respond to chemotherapy. This study opens up an interesting avenue of investigation to potentially identify predictive biomarkers and novel therapeutic targets for pancreatic cancer, a disease that has seen no significant improvement in survival over the past 40 years.


Subject(s)
Biomarkers, Tumor/metabolism , Pancreatic Neoplasms/metabolism , Sirtuin 3/metabolism , Sirtuins/metabolism , Antibody Specificity/immunology , Female , Humans , Immunohistochemistry , Male , Middle Aged , Pancreatic Neoplasms/drug therapy , Pancreatic Neoplasms/pathology , Prognosis , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...